<DOC>
	<DOCNO>NCT01211028</DOCNO>
	<brief_summary>The main purpose study evaluate safety feasibility regenerative therapy expand adipose derive stroma/stem cell sue , administer intramuscularly patient critical leg ischemia .</brief_summary>
	<brief_title>Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Severe peripheral vascular disease amenable bypass angioplasty Age &gt; 40 year old Normal renal function ( creatinine &lt; 1.6 ) Non pregnant female Lifespan &gt; 6 month Age &lt; 40 year old Refusal give inform consent and/orCognitively disable Congestive heart failure stroke last 3 month History cancer myeloproliferative disorder Proliferative retinopathy Pregnancy Positive screen test HIV , Hepatitis B Hepatitis C Buerger patient Cachexia predict impossibility biopsy least 30 gram fat tissue Pregnancy lactation Having non control severe pathology</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Critical leg ischemia</keyword>
	<keyword>Adipose derive Stroma/Stem Cells</keyword>
	<keyword>Autologous</keyword>
	<keyword>Angiogenesis</keyword>
</DOC>